NXLIW 0.40 Stock Price Nexalin Technology, Inc.
Range: | 0.4515-0.72 | Vol Avg: | 0 | Last Div: | 0 | Changes: | 0.03 |
Beta: | 3.57 | Cap: | 0.05B | Currency: | USD | Exchange: | NASDAQ |
Sector: | Healthcare | IPO: | Thu Jan 01 1970 | Empoloyees: | 6 |
CUSIP: | 65345B110 | CIK: | 0001527352 | ISIN: | US65345B1109 | Country: | US |
CEO: | Mr. Mark White | Website: | https://www.nexalin.com |
Nexalin Technology, Inc., a medical device company, designs and develops neurostimulation products for the treatment of mental health in the United States and China. It licenses and markets Nexalin Device, a non-invasive and drug-free therapy for the treatment of anxiety and insomnia. The company's Nexalin device emits a patented frequency-based waveform, which stimulates a positive response from the mid-brain structures associated with various mental health disorders. It also engages in the development of Generation 2, a medical device that is in clinical trials for the treatment of substance abuse issues related to opiates, chronic pain, Alzheimer's disease, and dementia. The company was incorporated in 2021 and is headquartered in Houston, Texas.
The content provided on this site is for informational purposes only and does not constitute financial, investment, or professional advice. We are not registered investment advisors or financial planners, and we do not provide recommendations or advice on buying, selling, or holding any particular stocks or securities. Any investment decisions should be made based on your own research and consultation with a qualified financial professional. We are not responsible for any financial loss or damages incurred from reliance on the information provided on this site. Please invest responsibly and seek professional advice when needed.